The U.S. Treasury Department's proposed restrictions cover equity interest acquisitions, debt financing, joint ventures, brain-computer interfaces, biomanufacturing equipment, and life sciences tools involving Chinese entities

From the articleTrump administration proposes new curbs on China biotech dealsAlso in Treasury proposes major restrictions to U.S. investment in Chinese biotech sector, US Proposes Curbs on Investment in Chinese Biotech Firms